Anil Patel
Pulmonary Disease · Virginia Beach, VANPI 1205942281
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pulmonary disease clinicians in VA, where the typical reported total is $1,962.
Across 98 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$382
- GSK$209
- Takeda Pharmaceuticals U.S.A., Inc.$180
- Boehringer Ingelheim$172
- Paratek Pharmaceuticals, Inc.$125
- United Therapeutics Corporation$120
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,223100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 13 | $382 |
| GSK | 6 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $180 |
| Boehringer Ingelheim | 9 | $172 |
| Paratek Pharmaceuticals, Inc. | 6 | $125 |
| United Therapeutics Corporation | 6 | $120 |
| Insmed, Inc. | 6 | $116 |
| Actelion Pharmaceuticals US, Inc. | 4 | $87 |
| Mylan Specialty L.p. | 6 | $85 |
| Grifols USA, LLC | 3 | $74 |
| Genentech USA, Inc. | 3 | $71 |
| Sunovion Pharmaceuticals Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $62 |
| AstraZeneca | 3 | $61 |
| Advanced Respiratory, Inc | 3 | $58 |
| Portola Pharmaceuticals, LLC | 3 | $55 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $48 |
| Johnson & Johnson | 1 | $47 |
| Sanofi | 2 | $40 |
| Gilead | 2 | $30 |
| Harmony Biosciences LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Pulmonx Corporation | 1 | $21 |
| Pfizer | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Circassia Inc. | 1 | $15 |
| Electromed, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$124
How this compares
$2,223 in reported general payments places this provider in the 50th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Virginia Beach
- Vasantha HathwarVirginia Beach$13K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Eric LibreAnnandale$302K
- Sujoy GillRichmond$296K
- Imre NothCharlottesville$256K
- Carlos SilvaChesapeake$245K
- Vijay SubramaniamWilliamsburg$228K
- Ellen VolkerCharlottesville$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.